Introduction
WNK (With-No-Lysine) kinases have been initially recognized in a display for novel members of the MAP kinase kinase (MAP2K) household (Xu et al., 2000; Verissimo and Jordan, 2001). The 4 WNK members of the family are characterised by an atypical placement of the catalytic lysine. These serine-threonine kinases take part in a number of functionally distinct signaling cascades controlling mobile responses to osmotic stress (Xu et al., 2005b; Kahle et al., 2005; Lenertz et al., 2005; Moriguchi et al., 2005; Anselmo et al., 2006; Gagnon et al., 2006; Vitari et al., 2006; Zagorska et al., 2007; Richardson et al., 2008; Roy et al., 2015). Many putative WNK substrates have been recognized; the best-known are the associated kinases OSR1 (oxidative stress responsive kinase1) and SPAK (STE20/SPS1-related proline/alanine-rich kinase) (Chen et al., 2004; Moriguchi et al., 2005; Vitari et al., 2005; Anselmo et al., 2006; Cope et al., 2006; Vitari et al., 2006; Richardson and Alessi, 2008). OSR1 and SPAK regulate ion co-transporters and can be mentioned additional beneath (Moriguchi et al., 2005; Vitari et al., 2005; Anselmo et al., 2006; Roy et al., 2015). In recent times, there may be rising proof that WNK1 is a vital kinase concerned in varied kinds of most cancers (Chen et al., 2017; Gallolu Kankanamalage et al., 2018; Shahi Thakuri et al., 2020), however the precise mechanisms by which WNK1 modulates tumor development are usually not effectively understood. Right here we summarize the construction and turnover of WNK1 protein and proof for its actions in tumor malignancy in human cancers.
Overview of With-No-Lysine kinases Construction and Expression
In people, the 4 WNK kinases, WNK1-4, vary in dimension from 2833 amino acids (the longest isoform of WNK1) to 1243 amino acids (WNK4) (Verissimo and Jordan, 2001; Wilson et al., 2001; Delaloy et al., 2003; Vidal-Petiot et al., 2012). The 4 WNK members of the family share excessive homology of their kinase domains with 85–90% sequence id, two autoinhibitory-like domains, a coiled-coil area, and proline-rich (PXXP) motifs for protein-protein interactions (Xu et al., 2000; Verissimo and Jordan, 2001; Wilson et al., 2001; Xu et al., 2005a; Huang et al., 2007; Wang et al., 2008). Crystal buildings of the kinase domains and autoinhibitory domains of a number of WNKs have been decided and a few buildings with small molecules certain can be found (Min et al., 2004; Xu et al., 2005a; Moon et al., 2013). Exterior of those areas, WNKs present low sequence id, which is assumed to confer purposeful range for every of the WNK members of the family. Additional, the abundance of low complexity sequence outdoors of the kinase area makes construction dedication difficult. Alphafold2 didn’t present a lot higher readability on the stability of the WNK1 molecule, for instance, (Jumper et al., 2021; Varadi et al., 2021).
WNK1 and WNK4 have been extensively studied as a result of they’re chargeable for pseudohypoaldosteronism sort II (PHA II), a genetic illness characterised by hyperkalemic hypertension (Wilson et al., 2001; Susa et al., 2014). In distinction to different members of the WNK household which show a extra tissue-restricted sample of expression, WNK1 is extensively and extremely expressed in most animal tissues and cell sorts (Xu et al., 2000; Wilson et al., 2001; O’reilly et al., 2003; Vitari et al., 2005). The sequence of WNK1 is conserved throughout species (human WNK1 > 85% an identical with mouse, pig 86%, rat 76%, and bovine 68%) and is recognizable in vegetation and plenty of unicellular eukaryotes. The kinase exercise of WNK1 is regulated by way of autophosphorylation on activation loop residues Ser382 and Ser378 (Xu et al., 2002). Particulars of mechanisms controlling autophosphorylation stay scant; nevertheless, importantly, chloride ion binding within the energetic website prevents autophosphorylation (Piala et al., 2014). This discovering is related to WNK operate as central regulators of ion homeostasis.
With-No-Lysine kinases1 Turnover and Ion Homeostasis
Resulting from its significance for mobile homeostasis (Shekarabi et al., 2017), the abundance of WNK1 protein is tightly managed by a number of layers of damaging regulation (Mccormick and Ellison, 2011; Li et al., 2014; Roy et al., 2015; Dbouk et al., 2016). The set level within the complete quantity of WNK1 protein in a cell has a considerable affect on management of its downstream targets. All WNK members of the family share the extremely conserved acidic degron motif close to their autoinhibitory area as a sign for destruction, which performs a vital function within the ubiquitin-dependent proteolytic course of (Schumacher et al., 2014; Chen et al., 2022). The preliminary discovering confirmed that the adaptor protein kelch-like member of the family 3 (KLHL3)-cullin3 (CUL3) E3 ligase complicated is related to WNK1 and WNK4 (Shibata et al., 2013). KLHL3 as a substrate adaptor binds to the conserved degron motif simply C-terminal to the kinase area in these WNKs to facilitate the recruitment of the CUL3 E3 ubiquitin ligase, thereby selling ubiquitination and degradation (Shibata et al., 2013; Schumacher et al., 2014). Perturbations on this interplay have nice results on WNK-mediated electrolyte homeostasis, which was demonstrated by the discovering that mutations in KLHL3-CUL3 additionally trigger PHA II (Ohta et al., 2013; Mccormick et al., 2014; Lin et al., 2019).
Different ubiquitination pathways have additionally been related to WNK1 turnover. The HECT-type ubiquitin ligase NEDD4-2 (additionally known as NEDD4L) can bind to PY motifs in WNK1 for facilitating its ubiquitin-dependent proteasomal degradation (Heise et al., 2010; Roy et al., 2015). That is supported by the discovering that WNK1 abundance was elevated and OSR1/SPAK activation have been noticed in mice missing NEDD4-2 (Roy et al., 2015; Al-Qusairi et al., 2017). We not too long ago confirmed that WNK1 is degraded not solely by the ubiquitin-proteasome pathway, but in addition by the lysosomal pathway (Jung et al., 2022). Non-lysosomal cysteine proteases calpain and caspase-3 have been additionally capable of affect WNK1 abundance. This research recognized UBR5 (ubiquitin protein ligase E3 part N-recognin 5) as a beforehand unknown regulator of WNK1 turnover that mediates lysosomal degradation of WNK1 protein (Jung et al., 2022). Although UBR5 inhibition solely modestly elevated WNK1 protein, that change brought about a major enhance in phosphorylation of OSR1/SPAK, indicating that even small modifications in WNK1 protein can have a major affect on mobile processes. It’s subsequently doubtless that a number of degradative pathways in cells take part within the modulation of mobile WNK1 protein quantity. WNK1 itself may also act as an adaptor for endosomal trafficking. WNK1 is considered essential for glucose transporter GLUT1 and GLUT4 endosomal trafficking by way of regulating the Rab GTPase-activating protein AS160 (Akt substrate of 160 kDa) (Mendes et al., 2010; Tan et al., 2012; Kim et al., 2018; Henriques et al., 2020). WNK1 interacts with the endocytic scaffold protein intersectin which is concerned in clathrin-mediated endocytosis that impacts recycling of ROMK (renal outer medullary potassium channel) (He et al., 2007; Wang et al., 2008). Furthermore, we beforehand discovered that WNK1 negatively regulates autophagic degradation pathways by way of inhibition of sophistication III phosphatidylinositol 3-kinase (PI3KC3) (Gallolu Kankanamalage et al., 2016). These outcomes suggest that WNK1 protein is degraded by a number of proteolytic pathways, whereas additionally it is a vital modulator of endocytic degradation. The mechanisms underlying the suggestions between WNK1 turnover and its operate as a trafficking regulator stay to be decided.
With-No-Lysine kinases1, Angiogenesis, and Cell Junction Regulation
Phenotypes recognized in mouse knockout research demonstrated that WNK1 is required for angiogenesis. Angiogenesis is a extremely regulated course of that’s turned on transiently throughout growth, copy, and wound restore, which includes formation of latest capillaries by way of sprouting or by splitting off from the unique vessel (intussusception) (Folkman and Shing, 1992; Otrock et al., 2007). Homozygous disruption of the WNK1 gene leads to a deadly developmental failure in mice round embryonic day E12, resulting from impaired angiogenesis (Xie et al., 2009; Xie et al., 2009). The phenotype of the WNK1 international knockout mouse mimics the defects brought on by endothelial-specific ablation of WNK1 and is rescued both by endothelial-specific expression of WNK1 (Xie et al., 2009) or an activated type of OSR1 (Xie et al., 2013). Moreover, depletion of WNK1 and OSR1 decreased in vitro vascular twine formation and cell migration in endothelial cells (Dbouk et al., 2014; Jaykumar et al., 2022), indicating an important function of WNK1-activated OSR1 signaling in angiogenesis, and vascular transforming.
Though an in depth mechanistic understanding of the consequences of WNK1 on angiogenesis is missing, decreased expression of WNK1 in cultured endothelial cells brought about lowered expression of a lot of elements that promote angiogenesis together with Slug (SNAI2), vascular endothelial progress issue A (VEGF-A), and matrix metallo-proteinases (MMPs) (Dbouk et al., 2014). Throughout vein graft transforming, Slug mediates endothelial-mesenchymal transition (additionally known as Endo-MT) by way of SMAD2/3-mediated remodeling progress factor-β (TGF-β) signaling (Cooley et al., 2014; Welch-Reardon et al., 2014; Mahmoud et al., 2017), a extensively recognized inducer of this transition (Nakajima et al., 2000; Pardali et al., 2017). We beforehand confirmed that WNK1 interacts with, and phosphorylates SMAD2 and regulates its operate (Lee et al., 2007; Li et al., 2020). WNK1 signaling takes half within the regulation of TGF-β/SMAD-dependent Endo-MT for selling onset of cell sprouting, migration and vascular transforming. These and different findings point out an impact of the WNK1 cascade on induction of a mesenchymal phenotype important for endothelial wound therapeutic (Yoshimatsu and Watabe, 2011; Welch-Reardon et al., 2014).
Partial Endo-MT is characterised by transient lack of an endothelial phenotype and acquisition of mesenchymal traits reminiscent of lack of cell-cell junctions, polarity and acquire of motility to advertise angiogenic sprouting and cell migration (Otrock et al., 2007; Welch-Reardon et al., 2015). TGF-β initiates cytoskeletal turnover and a drastic down-regulation and disintegration of tight junctions to advertise migration in endothelial cells. Upon TGF-β stimulation, the TGF-β receptor sort II redistributes into tight junctions which ends up in their dissolution (Barrios-Rodiles, 2005; Ozdamar et al., 2005). As a result of OSR1 is a mediator of WNK1 motion and since OSR1 was discovered to be a part of the TGF-β interactome (Barrios-Rodiles, 2005), we explored the chance that WNK1 regulates OSR1 to affect endothelial tight junction turnover. We discovered that OSR1 is concerned in WNK1-mediated regulation of turnover of tight junctions and adherens junctions, partly, by way of its interplay with occludin by way of a TGF-β-sensitive course of. Whereas occludin shouldn’t be mandatory for the formation of tight junctions, occludin is important to tight junction integrity (Rao, 2009; Cummins, 2011). Apparently, occludin can be vital for directional migration of epithelial cells (Du et al., 2010). Management of each tight junction integrity and directional migration of endothelial cells are central to angiogenesis (Liu et al., 2016). One mechanism underlying the significance of WNK1/OSR1 to angiogenesis is the capability to focus on occludin turnover. This similar capability may additionally contribute to results of the WNK1 pathway on endothelial-mesenchymal transition. Moreover, current research have proven that occludin can be concerned in endothelial neovascularization and angiogenesis (Liu et al., 2016). Along with results on occludin, we recognized different occasions that underlie WNK1-mediated management of angiogenesis together with stabilization of TGF-β-regulated parts AXL (a TAM receptor tyrosine kinase), ALK1 (a TGF-β receptor), SMAD2/3, RhoA, and VE-cadherin (Jaykumar et al., 2022).
Adherens junctions are required for endothelial cell stabilization and homeostasis as a result of they promote contact inhibition of progress and reduce cell responsiveness to apoptotic stimuli. Adherens junctions in endothelial cells primarily encompass VE-cadherin (Dejana, 2004; Rudini et al., 2008). VE-cadherin can be recognized to be an endothelial cell-specific regulator of TGF-β/SMAD signaling (Rudini et al., 2008). TGF-β induces TGF-βRII affiliation with VE-cadherin and this clustering promotes TGF-β signaling, which, in flip, destabilizes cell-cell junctions (Ma et al., 2020). Furthermore, VE-cadherin is important for TGF-β-induced endothelial cell migration (Rudini et al., 2008). VE-cadherin is a optimistic regulator of TGF-β-induced SMAD2/3 phosphorylation. TGF-β stimulation induces affiliation of VE-cadherin with TGF-βRII/TGF-βRI and subsequently it participates in maximal activation of the TGF-β pathway (Rudini et al., 2008). OSR1 was additionally proven to phosphorylate the SMAD2/3 linker area to advertise TGF-β signaling (Li et al., 2020). We discovered that WNK1 inhibition results in decreased localization of VE-cadherin at cell-cell junctions solely within the presence of TGF-β, indicating that WNK1 actions are context dependent (Jaykumar et al., 2022).
With-No-Lysine kinases1 and Most cancers Prognosis
For the final two a long time, the vast majority of research on WNK1 have targeted on their roles in hypertension and kidney operate. Though a number of research revealed that WNK1 is concerned in main cancer-related signaling pathways reminiscent of PI3K-AKT, TGF-β and NF-κB (Xu et al., 2005c; Jiang et al., 2005; Lee et al., 2007; Yan et al., 2008), little is understood relating to how WNK1 contributes to most cancers development. Lately, there was rising curiosity in involvement of WNK1 in cancers. In truth, large-scale most cancers database evaluation from the cBioPortal for Most cancers Genomics revealed {that a} excessive degree of WNK1 expression has been noticed in varied tumor sorts together with prostate, ovarian, testis and breast cancers (The cBioPortal for Most cancers Genomics; http://cbioportal.org). As famous above, upregulation of WNK1 protein can lead to elevated activation of its downstream pathways and potential cancer-promoting actions. Using transposon-mediated insertional mutagenesis for figuring out candidate BC driver genes, WNK1 was recognized as certainly one of a handful of driver genes in high-risk invasive breast most cancers (Chen et al., 2017).
Paralleling findings in endothelial cells, WNK1 has been implicated in migration with epithelial-mesenchymal (EMT) options by way of knockdown research in a number of most cancers sorts, and in addition as a contributor to stem-like properties in metastatic breast cancers (Shyamasundar et al., 2016; Hung et al., 2017; Pio et al., 2017). Mechanistic info has steered hyperlinks to expression of EMT elements Slug and Snail, microRNA networks, modifications in expression of cell floor proteins, altered vesicle trafficking, and results on actin polymerization (Shyamasundar et al., 2016; Hung et al., 2017; Tanaka and Siemann, 2019). One research confirmed that WNK protects the interplay between β-Catenin and the glucose-induced degradation poor (GID) complicated, which incorporates an E3 ubiquitin ligase focusing on β-Catenin, and that WNK regulates β-Catenin ranges. Moreover, WNK inhibitors induced β-Catenin degradation and suppressed xenograft tumor growth in mice (Sato et al., 2020). Elevated WNK1 mRNA and protein have been detected in hepatocellular carcinoma (HCC) and considerably correlated with poor prognosis, highlighting the medical significance of WNK1 in HCC development (Ho et al., 2020). Knockdown and inhibition of WNK1 additionally decreased tumor-induced ectopic vessel formation and inhibited tumor proliferation in two zebrafish fashions transplanted with intestinal and hepatocellular carcinomas (Sie et al., 2020). Endothelial-specific overexpression of WNK1 enhanced tumorigenesis in transgenic carcinogenic zebrafish, supporting endothelial cell-autonomous impact of WNK1 in tumor manufacturing (Sie et al., 2020). As well as, WNK1 fusion to B4GALNT3 is a possible oncogenic driver in a affected person with papillary thyroid carcinoma, which is the most typical sort of thyroid most cancers (Costa et al., 2015). One other newly recognized gene fusion WNK1-ROS1 (c-Ros oncogene-1) has been described as a novel driver of lung adenocarcinoma (Liu et al., 2019). WNK1 has been proven to advertise tumorigenesis in cancers by way of its capacity to advertise cell proliferation by way of anti-apoptotic and pro-survival capabilities (Tu et al., 2011; Fulford et al., 2016; Wang et al., 2017). Importantly, the WNK1 signaling axis contributes to pathologic options of malignancies reminiscent of enhanced invasion, migration, adhesion and tumorigenicity, as proven in Determine 1. Thus, interfering with WNK1 expression could have therapeutic worth in human cancers. Within the following sections, we focus on completely different mechanisms by which WNK1 has been reported to assist tumor malignancy.
FIGURE 1. Pathological impacts of WNK1 in most cancers. WNK1 regulates the expression of assorted molecules concerned in numerous features of oncogenesis. Created with BioRender.com.
With-No-Lysine kinases1 and Epithelial–Mesenchymal Transition
The most important attribute of malignant tumors is a diffuse invasion into adjoining regular tissue and migration to a major distance from the first tumor space, a basic step in metastasis (Van Zijl et al., 2011; Clark and Vignjevic, 2015; Lambert et al., 2017). This attribute is without doubt one of the most tough challenges to focus on therapeutically in human cancers. Due to this fact, a transparent understanding of the mobile and molecular mechanisms underlying the malignant habits is essential for the event of particular therapeutic methods.
A number of research have implicated WNKs in cell migration in wound therapeutic assays (Adams et al., 2017; Desjardins et al., 2019; Kim et al., 2019; Liu et al., 2020). A direct relationship between WNK1 and cell invasion in three-dimensional assays was described in human umbilical vein endothelial cells (HUVECs) (Dbouk et al., 2014). In that research, sprouting and invasion into the encircling matrix have been considerably diminished by WNK1 knockdown in spheroid sprouting assays. The impaired invasive phenotype of WNK1-depleted most cancers cells was linked to downregulation of the EMT-associated transcription issue Slug which was partially rescued by overexpressing the WNK1-regulated kinases OSR1 or SPAK (Jaykumar et al., 2021). In line with this, it has not too long ago been proposed that OSR1 depletion in MDA-MB-231 cells shows a lower in expression of EMT transcription elements Twist1, Snail, and Slug at mRNA and protein ranges, leading to lowered invasion of breast most cancers cells in vitro and in vivo (Li et al., 2021). As anticipated, OSR1 overexpression elevated ranges of EMT transcription elements (Li et al., 2021). The pathological significance of full or partial EMT has turn into clear from quite a few research and the molecular mechanisms governing malignant phenotypes of most cancers cells reminiscent of invasion and metastasis formation have gotten clearer (Dang et al., 2015; Brabletz et al., 2018; Ramesh et al., 2020; Ribatti et al., 2020). Inhibition of WNK signaling with WNK463, an allosteric inhibitor of WNK kinase exercise (Yamada et al., 2016; Zhang et al., 2016), considerably decreased expression of the EMT-related issue N-cadherin in breast most cancers cells (Jaykumar et al., 2021). This mesenchymal marker is usually extremely expressed in cancers and has been proven to be related to poor prognosis (Mariotti et al., 2007; Mrozik et al., 2018). Depletion of WNK1 in MDA-MB-231 cells considerably attenuated invasive potential in three-dimensional collagen matrices, and an identical end result was additionally noticed in cells handled with WNK463 (Jaykumar et al., 2021). In one other research in MDA-MB-231 cells, miRNA-93 was reported to suppress WNK1 expression, leading to a lower within the invasiveness of the cells by way of upregulation of epithelial markers CLDN1, CLDN3 and CDH1 (Shyamasundar et al., 2016). Moreover, it was proven that overexpression of WNK1 in hepatocellular carcinoma enhanced the expression of MMP-2 and MMP-9, that are EMT-related proteolytic enzymes that may promote degradation of the extracellular matrix, EMT, and invasion (Dong et al., 2020). Thus, various research place WNK1 as a regulator of EMT through the invasion of several types of most cancers cells.
Proof generated from a number of research means that WNK1 is a key in most cancers cell migration by way of regulation of EMT. For the reason that preliminary discovering by way of in vitro scratch wound therapeutic assays that knockdown of WNK1 lowered migration of mouse neural progenitor cell line C17.2 accompanied by morphological modifications (Solar et al., 2006), quite a few research have recognized WNK1 regulation of the migratory phenotype in most cancers cells. In non-small cell lung most cancers cell strains, WNK1 silencing results in decreased EMT molecules N-cadherin and Snail, and elevated E-cadherin, leading to lowered migration of CL1-5 and H1299 cells (Hung et al., 2017). Additionally, work from our lab has proven that WNK1 inhibition in 5 completely different breast most cancers cell strains MDA-MB-231, BT-549, BT-20, HCC1569, and HCC1419 considerably lowered the migratory capability concomitantly with the discount in N-cadherin protein expression (Jaykumar et al., 2021).
With-No-Lysine kinases, Ion Cotransporters and Migration
As mentioned above, the WNK-OSR1/SPAK signaling pathway is vital within the regulation of electrolyte homeostasis by way of regulating ion co-transporters of the SCL12A household. These embrace the Na+Ok+2Cl− co-transporters 1 and a couple of (NKCC1 and NKCC2), the Na+Cl− co-transporter (NCC), and a number of Ok+Cl− co-transporters (KCC) that modulate the flux of ions throughout the cell membrane (Gamba, 2005; Flatman, 2008; Richardson and Alessi, 2008). WNK1 has additionally been demonstrated to manage cell floor expression of ion channels together with the epithelial Na+ channel (ENaC) and renal outer medullary Ok+ channel (ROMK, Kir 1.1) (Xu et al., 2005b; Cope et al., 2006; Lazrak et al., 2006). We not too long ago confirmed that Kir2.1 and Kir2.3 channels harbor another SPAK/OSR1 binding motifs (RxFxV), resulting in their plasma membrane localization (Taylor et al., 2018). Alterations of electrolyte homeostasis are regularly noticed in most cancers sufferers (Miltiadous et al., 2008; Rosner and Dalkin, 2014; Li et al., 2020; Bennet et al., 2021).
These ion transporters and channels have regularly been implicated within the regulation of migration and invasion (Cuddapah and Sontheimer, 2011; Schwab and Inventory, 2014; Inventory and Schwab, 2015; Martial, 2016). WNK1 knockdown in main glioma cells leads to attenuated phosphorylation of NKCC1, the ubiquitously expressed ion co-transporter, in response to the chemotherapeutic drug temozolomide, decreasing glioma cell migration (Garzon-Muvdi et al., 2012). In an additional research, Köchl et al. described the mechanistic connection between WNK1 and NKCC1 on migration of T cells in vitro and in vivo. In that research, WNK1 was proven to negatively regulate integrin-mediated adhesion by way of inhibition of the small GTPase RAP1, and positively regulate migration by way of selling OSR1/SPAK-mediated NKCC1 activation, proposed to account for cell quantity modifications required for cell migration (Kochl et al., 2016). The significance of NKCC1 in most cancers cell invasion and migration is supported by research carried out in quite a few techniques. In glioblastoma cells, NKCC1 silencing impedes invasion and migration, accompanied by inhibition of MMP-2 and MMP-9 (Solar et al., 2020). The invasive capacity of hepatocellular carcinoma was regulated by NKCC1 (Zhou et al., 2017). We discovered that depletion of OSR1 additionally lowered migration of breast most cancers cells; nevertheless, inhibition of NKCC1 was not as efficient as OSR1 depletion in slowing migration (Jaykumar et al., 2021). Lastly, NKCC1 was reported to facilitate EMT of human gastric most cancers cells by way of the MAPK-JNK signaling pathway, leading to enhanced invasion and migration (Wang et al., 2021). WNK1 regulation of calcium homeostasis has been beforehand described (Lee et al., 2004; Xu et al., 2005a; Liu et al., 2015). A current research has hinted that actions of WNK1 on calcium homeostasis could take part in most cancers development. WNK1 impacts TRPC6 (canonical transient receptor potential channel)-mediated Ca2+ inflow, resulting in migration in clear-cell renal-cell carcinoma (Kim et al., 2019). These outcomes spotlight the purposeful significance of ion homeostasis regulated by WNK1 in most cancers cell invasion and migration.
With-No-Lysine kinases1 and AXL
Phenotypic plasticity in a number of cancers relies on the expression of the receptor tyrosine kinase AXL. In regular mammary epithelial cells, AXL is a driver of stemness (Fujino et al., 2017; Engelsen et al., 2020). Apparently, a number of traits of epithelial-mesenchymal transition overlap with these in endothelial cells (Welch-Reardon et al., 2015). Endothelial-expressed AXL is understood to modulate angiogenesis (Gallicchio et al., 2005; Sacha et al., 2005; Li et al., 2009). The catalytic exercise of AXL induces endothelial tube formation in vitro and knockdown of AXL in breast most cancers cells and in endothelial cell co-culture impairs this course of (Sacha et al., 2005; Li et al., 2009). AXL was recognized as a downstream effector of TGF-β and modulates expression of TGF-β/SMAD-dependent goal genes concerned in cell migration in hepatocellular carcinoma (Bauer et al., 2012; Lee et al., 2014; Reichl et al., 2015). Furthermore, inhibition of AXL decreases autocrine TGF-β signaling in hepatocellular carcinoma and impairs secretion of pro-angiogenic elements in breast most cancers cells which in flip impacts the operate of endothelial cells in co-culture and in vivo (Reichl et al., 2015; Tanaka and Siemann, 2019). Paracrine angiogenic elements have additionally been proven to be expressed in endothelial cells, suggestive of an autocrine signaling loop (Lee et al., 2007). In view of those observations, we investigated the potential of an AXL and WNK1 signaling collaboration in endothelial cells to manage endothelial cell migration and tube formation. We discovered that inhibiting WNK1 decreased expression of the tyrosine kinase AXL, apparently not resulting from a change in AXL mRNA (Jaykumar et al., 2021).
AXL expression is related to metastasis and poor prognosis in a wide range of tumor sorts together with breast most cancers (Oh et al., 2011; Dang et al., 2015; Garrido-Castro et al., 2019). BGB324 is a first-in-class AXL inhibitor, presently in section II medical trials, exhibiting promising therapeutic traits. It shows AXL-selective antitumor and antimetastatic exercise in murine fashions of breast most cancers (Garrido-Castro et al., 2019). AXL inhibition in tumor cells decreases the secretion of pro-angiogenic elements reminiscent of endothelin and VEGF-A and impairs purposeful properties of endothelial cells in vivo, suggesting its vital function within the initiation of tumor angiogenesis (Tanaka and Siemann, 2019). In our current research, we discovered elevated phospho-OSR1 in bone metastatic cells, suggesting that elevated WNK exercise could also be a function of breast cancers that may metastasize to a number of websites. We confirmed that inhibition of WNK1 reduces tumor quantity and dispersion of metastatic cells in a mouse xenograft mannequin of metastatic breast most cancers, partly, by way of a community involving Slug and AXL (Jaykumar et al., 2021). Apparently, we beforehand reported that mRNAs encoding these elements have been additionally decreased upon knockdown of WNK1 in endothelial cells (Dbouk et al., 2014). Maybe WNK1 knockdown diminishes these mRNAs partly by way of suppression of AXL (Dang et al., 2015). The connection revealed right here between AXL and WNK1 raises the chance that WNK1 could also be a therapeutic possibility in different AXL-dependent tumor sorts as effectively. We additionally discovered that inhibition of WNK1 by way of WNK463, had a extra pronounced impact than the AXL inhibitor to attenuate migration in MDA-MB-231 cells. But, the mixture of AXL and WNK inhibitors was more practical at decreasing migration than inhibition of both alone (Jaykumar et al., 2021). This remark warrants future research analyzing the mixture of AXL and WNK inhibitors on tumor development and metastasis in animal fashions, which might probably inform future medical trials (Determine 2).

FIGURE 2. Most cancers metastasis and angiogenesis by WNK1. WNK1 is a key within the metastasis cascade by way of regulation of EMT-effectors and -transcription elements. Created with BioRender.com.
Conclusion
In abstract, we briefly spotlight 4 factors that could be thought-about in future analyses of the actions of WNK1 and different WNK members of the family in cancers. It needs to be clear that WNK1 has associated actions in angiogenesis and most cancers. What number of of those associated actions are shared by different WNK members of the family shouldn’t be clear. The management WNK1 exerts over ion transport is a major think about its actions in cancers however could also be overshadowed by its potential affect on cell phenotype. In each endothelial cells and most cancers cells, WNK1 has the capability to induce migration and allow transition in the direction of a mesenchymal phenotype (Determine 2). This happens in sure contexts, e.g., in endothelial cells throughout wound restore, however what different triggers exist and what contexts decide when these actions of WNK1 will overtake its homeostatic capabilities are usually not established or but acknowledged. We shut with the query why and when does WNK1 swap from being a homeostatic housekeeper to as a substitute selling EMT.
Writer Contributions
All authors listed have made a considerable, direct, and mental contribution to the work and authorized it for publication.
Funding
Work by the authors that’s reviewed right here was supported by CPRIT coaching grant RP210041 to J-UJ, NIH R01 HL147661 and I1243 from Welch Basis to MC.
Battle of Curiosity
The authors declare that the analysis was performed within the absence of any business or monetary relationships that might be construed as a possible battle of curiosity.
Writer’s Notice
All claims expressed on this article are solely these of the authors and don’t essentially characterize these of their affiliated organizations, or these of the writer, the editors and the reviewers. Any product that could be evaluated on this article, or declare that could be made by its producer, shouldn’t be assured or endorsed by the writer.
Acknowledgments
We thank members of the Cobb laboratory and Grey Pearson (Georgetown College) for discussing this work and Dionne Ware for administrative assist.
References
Adams, N. R., Vasquez, Y. M., Mo, Q., Gibbons, W., Kovanci, E., and Demayo, F. J. (2017). WNK Lysine Poor Protein Kinase 1 Regulates Human Endometrial Stromal Cell Decidualization, Proliferation, and Migration in Half by way of Mitogen-Activated Protein Kinase 7. Biol. Reprod. 97, 400–412. doi:10.1093/biolre/iox108
PubMed Summary | CrossRef Full Textual content | Google Scholar
Al-Qusairi, L., Basquin, D., Roy, A., Rajaram, R. D., Maillard, M. P., Subramanya, A. R., et al. (2017). Renal Tubular Ubiquitin-Protein Ligase NEDD4-2 Is Required for Renal Adaptation throughout Lengthy-Time period Potassium Depletion. J. Am. Soc. Nephrol. 28, 2431–2442. doi:10.1681/asn.2016070732
PubMed Summary | CrossRef Full Textual content | Google Scholar
Anselmo, A. N., Earnest, S., Chen, W., Juang, Y.-C., Kim, S. C., Zhao, Y., et al. (2006). WNK1 and OSR1 Regulate the Na + , Ok + , 2Cl − Cotransporter in HeLa Cells. Proc. Natl. Acad. Sci. U.S.A. 103, 10883–10888. doi:10.1073/pnas.0604607103
PubMed Summary | CrossRef Full Textual content | Google Scholar
Barrios-Rodiles, M., Brown, Ok. R., Ozdamar, B., Bose, R., Liu, Z., Donovan, R. S., et al. (2005). Excessive-Throughput Mapping of a Dynamic Signaling Community in Mammalian Cells. Science 307, 1621–1625. doi:10.1126/science.1105776
PubMed Summary | CrossRef Full Textual content | Google Scholar
Bauer, T., Zagórska, A., Jurkin, J., Yasmin, N., Köffel, R., Richter, S., et al. (2012). Identification of Axl as a Downstream Effector of TGF-Β1 throughout Langerhans Cell Differentiation and Epidermal Homeostasis. J. Exp. Med. 209, 2033–2047. doi:10.1084/jem.20120493
PubMed Summary | CrossRef Full Textual content | Google Scholar
Bennet, D., Khorsandian, Y., Pelusi, J., Mirabella, A., Pirrotte, P., and Zenhausern, F. (2021). Molecular and Bodily Applied sciences for Monitoring Fluid and Electrolyte Imbalance: A Deal with Most cancers Inhabitants. Clin. Transl. Med. 11, e461. doi:10.1002/ctm2.461
PubMed Summary | CrossRef Full Textual content | Google Scholar
Chen, W., Yazicioglu, M., and Cobb, M. H. (2004). Characterization of OSR1, a Member of the Mammalian Ste20p/germinal Middle Kinase Subfamily. J. Biol. Chem. 279, 11129–11136. doi:10.1074/jbc.m313562200
PubMed Summary | CrossRef Full Textual content | Google Scholar
Chen, L., Jenjaroenpun, P., Pillai, A. M., Ivshina, A. V., Ow, G. S., Efthimios, M., et al. (2017). Transposon Insertional Mutagenesis in Mice Identifies Human Breast Most cancers Susceptibility Genes and Signatures for Stratification. Proc. Natl. Acad. Sci. U. S. A. 114, E2215–E2224. doi:10.1073/pnas.1701512114
PubMed Summary | CrossRef Full Textual content | Google Scholar
Chen, Z., Zhang, J., Murillo-De-Ozores, A. R., Castañeda-Bueno, M., D’amico, F., Heilig, R., et al. (2022). Sequence and Structural Variations Figuring out the Recruitment of WNK Kinases to the KLHL3 E3 Ligase. Biochem. J. 479, 661–675. doi:10.1042/bcj20220019
PubMed Summary | CrossRef Full Textual content | Google Scholar
Cooley, B. C., Nevado, J., Mellad, J., Yang, D., St Hilaire, C., Negro, A., et al. (2014). TGF-β Signaling Mediates Endothelial-To-Mesenchymal Transition (EndMT) throughout Vein Graft Reworking. Sci. Transl. Med. 6, 227ra34. doi:10.1126/scitranslmed.3006927
PubMed Summary | CrossRef Full Textual content | Google Scholar
Cope, G., Murthy, M., Golbang, A. P., Hamad, A., Liu, C.-H., Cuthbert, A. W., et al. (2006). WNK1 Impacts Floor Expression of the ROMK Potassium Channel Impartial of WNK4. J. Am. Soc. Nephrol. 17, 1867–1874. doi:10.1681/asn.2005111224
PubMed Summary | CrossRef Full Textual content | Google Scholar
Costa, V., Esposito, R., Ziviello, C., Sepe, R., Bim, L. V., Cacciola, N. A., et al. (2015). New Somatic Mutations andWNK1-B4GALNT3gene Fusion in Papillary Thyroid Carcinoma. Oncotarget 6, 11242–11251. doi:10.18632/oncotarget.3593
PubMed Summary | CrossRef Full Textual content | Google Scholar
Cuddapah, V. A., and Sontheimer, H. (2011). Ion Channels and Tranporters in Most cancers. 2. Ion Channels and the Management of Most cancers Cell Migration. Am. J. Physiology-Cell Physiology 301, C541–C549. doi:10.1152/ajpcell.00102.2011
Dang, T. T., Esparza, M. A., Maine, E. A., Westcott, J. M., and Pearson, G. W. (2015). ΔNp63α Promotes Breast Most cancers Cell Motility by way of the Selective Activation of Elements of the Epithelial-To-Mesenchymal Transition Program. Most cancers Res. 75, 3925–3935. doi:10.1158/0008-5472.can-14-3363
PubMed Summary | CrossRef Full Textual content | Google Scholar
Dbouk, H. A., Weil, L. M., Perera, G. Ok. S., Dellinger, M. T., Pearson, G., Brekken, R. A., et al. (2014). Actions of the Protein Kinase WNK1 on Endothelial Cells Are Differentially Mediated by its Substrate Kinases OSR1 and SPAK. Proc. Natl. Acad. Sci. U.S.A. 111 (45), 15999–16004. doi:10.1073/pnas.1419057111
PubMed Summary | CrossRef Full Textual content | Google Scholar
Delaloy, C., Lu, J., Houot, A.-M., Disse-Nicodeme, S., Gasc, J.-M., Corvol, P., et al. (2003). A number of Promoters within the WNK1 Gene: One Controls Expression of a Kidney-specific Kinase-Faulty Isoform. Mol. Cell. Biol. 23, 9208–9221. doi:10.1128/mcb.23.24.9208-9221.2003
PubMed Summary | CrossRef Full Textual content | Google Scholar
Desjardins, P., Couture, C., Germain, L., and Guérin, S. L. (2019). Contribution of the WNK1 Kinase to Corneal Wound Therapeutic Utilizing the Tissue‐engineered Human Cornea as an In Vitro Mannequin. J. Tissue Eng. Regen. Med. 13, 1595–1608. doi:10.1002/time period.2912
PubMed Summary | CrossRef Full Textual content | Google Scholar
Dong, H., Jian, P., Yu, M., and Wang, L. (2020). Silencing of Lengthy Noncoding RNA LEF1‐AS1 Prevents the Development of Hepatocellular Carcinoma by way of the Crosstalk with microRNA‐136‐5p/WNK1. J. Cell. Physiology 235, 6548–6562. doi:10.1002/jcp.29503
PubMed Summary | CrossRef Full Textual content | Google Scholar
Du, D., Xu, F., Yu, L., Zhang, C., Lu, X., Yuan, H., et al. (2010). The Tight Junction Protein, Occludin, Regulates the Directional Migration of Epithelial Cells. Dev. Cell. 18, 52–63. doi:10.1016/j.devcel.2009.12.008
PubMed Summary | CrossRef Full Textual content | Google Scholar
Engelsen, A. S. T., Wnuk-Lipinska, Ok., Bougnaud, S., Pelissier Vatter, F. A., Tiron, C., Villadsen, R., et al. (2020). AXL Is a Driver of Stemness in Regular Mammary Gland and Breast Most cancers. iScience 23, 101649. doi:10.1016/j.isci.2020.101649
PubMed Summary | CrossRef Full Textual content | Google Scholar
Fujino, N., Kubo, H., and Maciewicz, R. A. (2017). Phenotypic Screening Identifies Axl Kinase as a Unfavorable Regulator of an Alveolar Epithelial Cell Phenotype. Lab. Make investments. 97, 1047–1062. doi:10.1038/labinvest.2017.52
PubMed Summary | CrossRef Full Textual content | Google Scholar
Fulford, L., Milewski, D., Ustiyan, V., Ravishankar, N., Cai, Y., Le, T., et al. (2016). The Transcription Issue FOXF1 Promotes Prostate Most cancers by Stimulating the Mitogen-Activated Protein Kinase ERK5. Sci. Sign 9, ra48. doi:10.1126/scisignal.aad5582
PubMed Summary | CrossRef Full Textual content | Google Scholar
Gagnon, Ok. B. E., England, R., and Delpire, E. (2006). Quantity Sensitivity of Cation-Cl−cotransporters Is Modulated by the Interplay of Two Kinases: Ste20-Associated Proline-Alanine-Wealthy Kinase and WNK4. Am. J. Physiology-Cell Physiology 290, C134–C142. doi:10.1152/ajpcell.00037.2005
PubMed Summary | CrossRef Full Textual content | Google Scholar
Gallicchio, M., Mitola, S., Valdembri, D., Fantozzi, R., Varnum, B., Avanzi, G. C., et al. (2005). Inhibition of Vascular Endothelial Development Issue Receptor 2-mediated Endothelial Cell Activation by Axl Tyrosine Kinase Receptor. Blood 105, 1970–1976. doi:10.1182/blood-2004-04-1469
PubMed Summary | CrossRef Full Textual content | Google Scholar
Gallolu Kankanamalage, S., Lee, A.-Y., Wichaidit, C., Lorente-Rodriguez, A., Shah, A. M., Stippec, S., et al. (2016). Multistep Regulation of Autophagy by WNK1. Proc. Natl. Acad. Sci. U.S.A. 113, 14342–14347. doi:10.1073/pnas.1617649113
PubMed Summary | CrossRef Full Textual content | Google Scholar
Garrido-Castro, A. C., Lin, N. U., and Polyak, Ok. (2019). Insights into Molecular Classifications of Triple-Unfavorable Breast Most cancers: Bettering Affected person Choice for Therapy. Most cancers Discov. 9, 176–198. doi:10.1158/2159-8290.cd-18-1177
PubMed Summary | CrossRef Full Textual content | Google Scholar
Garzon-Muvdi, T., Schiapparelli, P., Ap Rhys, C., Guerrero-Cazares, H., Smith, C., Kim, D.-H., et al. (2012). Regulation of Mind Tumor Dispersal by NKCC1 by way of a Novel Function in Focal Adhesion Regulation. PLoS Biol. 10, e1001320. doi:10.1371/journal.pbio.1001320
PubMed Summary | CrossRef Full Textual content | Google Scholar
Heise, C. J., Xu, B.-e., Deaton, S. L., Cha, S.-Ok., Cheng, C.-J., Earnest, S., et al. (2010). Serum and Glucocorticoid-Induced Kinase (SGK) 1 and the Epithelial Sodium Channel Are Regulated by A number of with No Lysine (WNK) Household Members. J. Biol. Chem. 285, 25161–25167. doi:10.1074/jbc.m110.103432
PubMed Summary | CrossRef Full Textual content | Google Scholar
Henriques, A. F. A., Matos, P., Carvalho, A. S., Azkargorta, M., Elortza, F., Matthiesen, R., et al. (2020). WNK1 Phosphorylation Websites in TBC1D1 and TBC1D4 Modulate Cell Floor Expression of GLUT1. Archives Biochem. Biophysics 679, 108223. doi:10.1016/j.abb.2019.108223
PubMed Summary | CrossRef Full Textual content | Google Scholar
Ho, Y.-J., Chang, J., Yeh, Ok.-T., Gong, Z., Lin, Y.-M., and Lu, J.-W. (2020). Prognostic and Scientific Implications of WNK Lysine Poor Protein Kinase 1 Expression in Sufferers with Hepatocellular Carcinoma. Vivo 34, 2631–2640. doi:10.21873/invivo.12081
PubMed Summary | CrossRef Full Textual content | Google Scholar
Holland, S. J., Powell, M. J., Franci, C., Chan, E. W., Friera, A. M., Atchison, R. E., et al. (2005). A number of Roles for the Receptor Tyrosine Kinase Axl in Tumor Formation. Most cancers Res. 65, 9294–9303. doi:10.1158/0008-5472.CAN-05-0993
PubMed Summary | CrossRef Full Textual content | Google Scholar
Huang, C.-L., Cha, S.-Ok., Wang, H.-R., Xie, J., and Cobb, M. H. (2007). WNKs: Protein Kinases with a Distinctive Kinase Area. Exp. Mol. Med. 39, 565–573. doi:10.1038/emm.2007.62
PubMed Summary | CrossRef Full Textual content | Google Scholar
Hung, J.-Y., Yen, M.-C., Jian, S.-F., Wu, C.-Y., Chang, W.-A., Liu, Ok.-T., et al. (2017). Secreted Protein Acidic and Wealthy in Cysteine (SPARC) Induces Cell Migration and Epithelial Mesenchymal Transition by way of WNK1/snail in Non-small Cell Lung Most cancers. Oncotarget 8, 63691–63702. doi:10.18632/oncotarget.19475
PubMed Summary | CrossRef Full Textual content | Google Scholar
Jaykumar, A. B., Jung, J.-U., Parida, P. Ok., Dang, T. T., Wichaidit, C., Kannangara, A. R., et al. (2021). WNK1 Enhances Migration and Invasion in Breast Most cancers Fashions. Mol. Most cancers Ther. 20, 1800–1808. doi:10.1158/1535-7163.mct-21-0174
PubMed Summary | CrossRef Full Textual content | Google Scholar
Jaykumar, A. B., Plumber, S., Barry, D. M., Binns, D., Wichaidit, C., Grzemska, M., et al. (2022). WNK1 Collaborates with TGF-β in Endothelial Cell Junction Turnover and Angiogenesis. Proc. Natl. Acad. Sci. U. S. A. (In Press).
Jiang, Z. Y., Zhou, Q. L., Holik, J., Patel, S., Leszyk, J., Coleman, Ok., et al. (2005). Identification of WNK1 as a Substrate of Akt/protein Kinase B and a Unfavorable Regulator of Insulin-Stimulated Mitogenesis in 3T3-L1 Cells. J. Biol. Chem. 280, 21622–21628. doi:10.1074/jbc.m414464200
PubMed Summary | CrossRef Full Textual content | Google Scholar
Jumper, J., Evans, R., Pritzel, A., Inexperienced, T., Figurnov, M., Ronneberger, O., et al. (2021). Extremely Correct Protein Construction Prediction with AlphaFold. Nature 596, 583–589. doi:10.1038/s41586-021-03819-2
PubMed Summary | CrossRef Full Textual content | Google Scholar
Jung, J. U., Ghosh, A., Earnest, S., Deaton, S. L., and Cobb, M. H. (2022). UBR5 Is a Novel Regulator of WNK1 Stability. Am. J. Physiol. Cell. Physiol. 322, C1176–C1186. doi:10.1152/ajpcell.00417.2021
PubMed Summary | CrossRef Full Textual content | Google Scholar
Kahle, Ok. T., Rinehart, J., De Los Heros, P., Louvi, A., Meade, P., Vazquez, N., et al. (2005). WNK3 Modulates Transport of Cl – in and Out of Cells: Implications for Management of Cell Quantity and Neuronal Excitability. Proc. Natl. Acad. Sci. U.S.A. 102, 16783–16788. doi:10.1073/pnas.0508307102
PubMed Summary | CrossRef Full Textual content | Google Scholar
Kim, J. H., Kim, H., Hwang, Ok. H., Chang, J. S., Park, Ok. S., Cha, S. Ok., et al. (2018). WNK1 Kinase Is Important for Insulin‐stimulated GLUT4 Trafficking in Skeletal Muscle. FEBS Open Bio 8, 1866–1874. doi:10.1002/2211-5463.12528
PubMed Summary | CrossRef Full Textual content | Google Scholar
Kim, J. H., Hwang, Ok. H., Eom, M., Kim, M., Park, E. Y., Jeong, Y., et al. (2019). WNK1 Promotes Renal Tumor Development by Activating TRPC6‐NFAT Pathway. FASEB J. 33, 8588–8599. doi:10.1096/fj.201802019rr
PubMed Summary | CrossRef Full Textual content | Google Scholar
Köchl, R., Thelen, F., Vanes, L., Brazão, T. F., Fountain, Ok., Xie, J., et al. (2016). WNK1 Kinase Balances T Cell Adhesion versus Migration In Vivo. Nat. Immunol. 17, 1075–1083. doi:10.1038/ni.3495
PubMed Summary | CrossRef Full Textual content | Google Scholar
Lazrak, A., Liu, Z., and Huang, C.-L. (2006). Antagonistic Regulation of ROMK by Lengthy and Kidney-specific WNK1 Isoforms. Proc. Natl. Acad. Sci. U.S.A. 103, 1615–1620. doi:10.1073/pnas.0510609103
PubMed Summary | CrossRef Full Textual content | Google Scholar
Lee, B.-H., Min, X., Heise, C. J., Xu, B.-e., Chen, S., Shu, H., et al. (2004). WNK1 Phosphorylates Synaptotagmin 2 and Modulates its Membrane Binding. Mol. Cell. 15, 741–751. doi:10.1016/j.molcel.2004.07.018
PubMed Summary | CrossRef Full Textual content | Google Scholar
Lee, B.-H., Chen, W., Stippec, S., and Cobb, M. H. (2007). Organic Cross-Discuss between WNK1 and the Reworking Development Issue β-Smad Signaling Pathway. J. Biol. Chem. 282, 17985–17996. doi:10.1074/jbc.m702664200
PubMed Summary | CrossRef Full Textual content | Google Scholar
Lee, H.-J., Jeng, Y.-M., Chen, Y.-L., Chung, L., and Yuan, R.-H. (2014). Gas6/Axl Pathway Promotes Tumor Invasion by way of the Transcriptional Activation of Slug in Hepatocellular Carcinoma. Carcinogenesis 35, 769–775. doi:10.1093/carcin/bgt372
PubMed Summary | CrossRef Full Textual content | Google Scholar
Lenertz, L. Y., Lee, B.-H., Min, X., Xu, B.-e., Wedin, Ok., Earnest, S., et al. (2005). Properties of WNK1 and Implications for Different Household Members. J. Biol. Chem. 280, 26653–26658. doi:10.1074/jbc.m502598200
PubMed Summary | CrossRef Full Textual content | Google Scholar
Li, Y., Ye, X., Tan, C., Hongo, J.-A., Zha, J., Liu, J., et al. (2009). Axl as a Potential Therapeutic Goal in Most cancers: Function of Axl in Tumor Development, Metastasis and Angiogenesis. Oncogene 28, 3442–3455. doi:10.1038/onc.2009.212
PubMed Summary | CrossRef Full Textual content | Google Scholar
Li, C., Feng, M., Shi, Z., Hao, Q., Music, X., Wang, W., et al. (2014). Structural and Biochemical Insights into the Activation Mechanisms of Germinal Middle Kinase OSR1. J. Biol. Chem. 289, 35969–35978. doi:10.1074/jbc.m114.592097
PubMed Summary | CrossRef Full Textual content | Google Scholar
Li, Y., Chen, X., Shen, Z., Wang, Y., Hu, J., Xu, J., et al. (2020). Electrolyte and Acid-Base Problems in Most cancers Sufferers and its Influence on Scientific Outcomes: Proof from a Actual-World Research in China. Ren. Fail. 42, 234–243. doi:10.1080/0886022x.2020.1735417
PubMed Summary | CrossRef Full Textual content | Google Scholar
Li, Y., Li, L., Qin, J., Wu, J., Dai, X., and Xu, J. (2021). OSR1 Phosphorylates the Smad2/3 Linker Area and Induces TGF-Β1 Autocrine to Promote EMT and Metastasis in Breast Most cancers. Oncogene 40, 68–84. doi:10.1038/s41388-020-01499-2
PubMed Summary | CrossRef Full Textual content | Google Scholar
Lin, C.-M., Cheng, C.-J., Yang, S.-S., Tseng, M.-H., Yen, M.-T., Sung, C.-C., et al. (2019). Era and Evaluation of a Mouse Mannequin of Pseudohypoaldosteronism Sort II Brought on by KLHL3 Mutation in BTB Area. FASEB J. 33, 1051–1061. doi:10.1096/fj.201801023r
PubMed Summary | CrossRef Full Textual content | Google Scholar
Liu, X., Dreffs, A., Díaz-Coránguez, M., Runkle, E. A., Gardner, T. W., Chiodo, V. A., et al. (2016). Occludin S490 Phosphorylation Regulates Vascular Endothelial Development Issue-Induced Retinal Neovascularization. Am. J. Pathology 186, 2486–2499. doi:10.1016/j.ajpath.2016.04.018
PubMed Summary | CrossRef Full Textual content | Google Scholar
Liu, Y., Liu, T., Li, N., Wang, T., Pu, Y., and Lin, R. (2019). Identification of a Novel WNK1-ROS1 Fusion in a Lung Adenocarcinoma Delicate to Crizotinib. Lung Most cancers 129, 92–94. doi:10.1016/j.lungcan.2018.12.011
PubMed Summary | CrossRef Full Textual content | Google Scholar
Liu, Y., Music, X., Shi, Y., Shi, Z., Niu, W., Feng, X., et al. (2015). WNK1 Prompts Massive-Conductance Ca2+-Activated Ok+Channels by way of Modulation of ERK1/2 Signaling. J. Am. Soc. Nephrol. 26, 844–854. doi:10.1681/asn.2014020186
PubMed Summary | CrossRef Full Textual content | Google Scholar
Liu, Z., Yoon, J., Wichaidit, C., Jaykumar, A. B., Dbouk, H. A., Embry, A. E., et al. (2020). Management of Podocyte and Glomerular Capillary Wall Construction and Elasticity by WNK1 Kinase. Entrance. Cell. Dev. Biol. 8, 618898. doi:10.3389/fcell.2020.618898
PubMed Summary | CrossRef Full Textual content | Google Scholar
Ma, J., Sanchez-Duffhues, G., Goumans, M.-J., and Ten Dijke, P. (2020). TGF-β-Induced Endothelial to Mesenchymal Transition in Illness and Tissue Engineering. Entrance. Cell. Dev. Biol. 8, 260. doi:10.3389/fcell.2020.00260
PubMed Summary | CrossRef Full Textual content | Google Scholar
Mahmoud, M. M., Serbanovic-Canic, J., Feng, S., Souilhol, C., Xing, R., Hsiao, S., et al. (2017). Shear Stress Induces Endothelial-To-Mesenchymal Transition by way of the Transcription Issue Snail. Sci. Rep. 7, 3375. doi:10.1038/s41598-017-03532-z
PubMed Summary | CrossRef Full Textual content | Google Scholar
Mariotti, A., Perotti, A., Sessa, C., and Rüegg, C. (2007). N-cadherin as a Therapeutic Goal in Most cancers. Skilled Opin. Investigational Medicine 16, 451–465. doi:10.1517/13543784.16.4.451
Martial, S. (2016). Involvement of Ion Channels and Transporters in Carcinoma Angiogenesis and Metastasis. Am. J. Physiology-Cell Physiology 310, C710–C727. doi:10.1152/ajpcell.00218.2015
Mccormick, J. A., Yang, C.-L., Zhang, C., Davidge, B., Blankenstein, Ok. I., Terker, A. S., et al. (2014). Hyperkalemic Hypertension-Related Cullin 3 Promotes WNK Signaling by Degrading KLHL3. J. Clin. Make investments. 124, 4723–4736. doi:10.1172/jci76126
PubMed Summary | CrossRef Full Textual content | Google Scholar
Mendes, A. I., Matos, P., Moniz, S., and Jordan, P. (2010). Protein Kinase WNK1 Promotes Cell Floor Expression of Glucose Transporter GLUT1 by Regulating a Tre-2/usp6-BUB2-Cdc16 Area Household Member 4 (TBC1D4)-Rab8A Complicated. J. Biol. Chem. 285, 39117–39126. doi:10.1074/jbc.m110.159418
PubMed Summary | CrossRef Full Textual content | Google Scholar
Miltiadous, G., Christidis, D., Kalogirou, M., and Elisaf, M. (2008). Causes and Mechanisms of Acid-Base and Electrolyte Abnormalities in Most cancers Sufferers. Eur. J. Intern. Med. 19, 1–7. doi:10.1016/j.ejim.2007.04.016
PubMed Summary | CrossRef Full Textual content | Google Scholar
Min, X., Lee, B.-H., Cobb, M. H., and Goldsmith, E. J. (2004). Crystal Construction of the Kinase Area of WNK1, a Kinase that Causes a Hereditary Type of Hypertension. Construction 12, 1303–1311. doi:10.1016/j.str.2004.04.014
PubMed Summary | CrossRef Full Textual content | Google Scholar
Moon, T. M., Correa, F., Kinch, L. N., Piala, A. T., Gardner, Ok. H., and Goldsmith, E. J. (2013). Answer Construction of the WNK1 Autoinhibitory Area, a WNK-specific PF2 Area. J. Mol. Biol. 425, 1245–1252. doi:10.1016/j.jmb.2013.01.031
PubMed Summary | CrossRef Full Textual content | Google Scholar
Moriguchi, T., Urushiyama, S., Hisamoto, N., Iemura, S.-i., Uchida, S., Natsume, T., et al. (2005). WNK1 Regulates Phosphorylation of Cation-Chloride-Coupled Cotransporters by way of the STE20-Associated Kinases, SPAK and OSR1. J. Biol. Chem. 280, 42685–42693. doi:10.1074/jbc.m510042200
PubMed Summary | CrossRef Full Textual content | Google Scholar
Mrozik, Ok. M., Blaschuk, O. W., Cheong, C. M., Zannettino, A. C. W., and Vandyke, Ok. (2018). N-cadherin in Most cancers Metastasis, its Rising Function in Haematological Malignancies and Potential as a Therapeutic Goal in Most cancers. BMC Most cancers 18, 939. doi:10.1186/s12885-018-4845-0
PubMed Summary | CrossRef Full Textual content | Google Scholar
Nakajima, Y., Yamagishi, T., Hokari, S., and Nakamura, H. (2000). Mechanisms Concerned in Valvuloseptal Endocardial Cushion Formation in Early Cardiogenesis: Roles of Reworking Development Issue (TGF)-β and Bone Morphogenetic Protein (BMP). Anat. Rec. 258, 119–127. doi:10.1002/(sici)1097-0185(20000201)258:2<119:aid-ar1>3.0.co;2-u
PubMed Summary | CrossRef Full Textual content | Google Scholar
O’reilly, M., Marshall, E., Speirs, H. J., and Brown, R. W. (2003). WNK1, a Gene inside a Novel Blood Stress Management Pathway, Tissue-Particularly Generates Radically Completely different Isoforms with and with no Kinase Area. J. Am. Soc. Nephrol. 14, 2447–2456. doi:10.1097/01.asn.0000089830.97681.3b
PubMed Summary | CrossRef Full Textual content | Google Scholar
Oh, J.-E., Kim, R. H., Shin, Ok.-H., Park, N.-H., and Kang, M. Ok. (2011). ΔNp63α Protein Triggers Epithelial-Mesenchymal Transition and Confers Stem Cell Properties in Regular Human Keratinocytes. J. Biol. Chem. 286 (44), 38757–38767. doi:10.1074/jbc.m111.244939
PubMed Summary | CrossRef Full Textual content | Google Scholar
Ohta, A., Schumacher, F.-R., Mehellou, Y., Johnson, C., Knebel, A., Macartney, T. J., et al. (2013). The CUL3-KLHL3 E3 Ligase Complicated Mutated in Gordon’s Hypertension Syndrome Interacts with and Ubiquitylates WNK Isoforms: Illness-Inflicting Mutations in KLHL3 and WNK4 Disrupt Interplay. Biochem. J. 451, 111–122. doi:10.1042/bj20121903
PubMed Summary | CrossRef Full Textual content | Google Scholar
Otrock, Z., Mahfouz, R., Makarem, J., and Shamseddine, A. (2007). Understanding the Biology of Angiogenesis: Evaluation of the Most Necessary Molecular Mechanisms. Blood Cells, Mol. Dis. 39, 212–220. doi:10.1016/j.bcmd.2007.04.001
PubMed Summary | CrossRef Full Textual content | Google Scholar
Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H.-R., Zhang, Y., and Wrana, J. L. (2005). Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity. Science 307, 1603–1609. doi:10.1126/science.1105718
PubMed Summary | CrossRef Full Textual content | Google Scholar
Pardali, E., Sanchez-Duffhues, G., Gomez-Puerto, M., and Ten Dijke, P. (2017). TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Illnesses. Int. J. Mol. Sci. 18, 2157. doi:10.3390/ijms18102157
PubMed Summary | CrossRef Full Textual content | Google Scholar
Piala, A. T., Moon, T. M., Akella, R., He, H., Cobb, M. H., and Goldsmith, E. J. (2014). Chloride Sensing by WNK1 Entails Inhibition of Autophosphorylation. Sci Sign 7, ra41.
PubMed Summary | CrossRef Full Textual content | Google Scholar
Pio, G. M., Xia, Y., Piaseczny, M. M., Chu, J. E., and Allan, A. L. (2017). Soluble Bone-Derived Osteopontin Promotes Migration and Stem-like Conduct of Breast Most cancers Cells. PLoS ONE 12, e0177640. doi:10.1371/journal.pone.0177640
PubMed Summary | CrossRef Full Textual content | Google Scholar
Reichl, P., Dengler, M., vanZijl, F., Huber, H., Führlinger, G., Reichel, C., et al. (2015). Axl Prompts Autocrine Reworking Development Issue‐β Signaling in Hepatocellular Carcinoma. Hepatology 61, 930–941. doi:10.1002/hep.27492
PubMed Summary | CrossRef Full Textual content | Google Scholar
Richardson, C., and Alessi, D. R. (2008). The Regulation of Salt Transport and Blood Stress by the WNK-SPAK/OSR1 Signalling Pathway. J. Cell. Sci. 121, 3293–3304. doi:10.1242/jcs.029223
PubMed Summary | CrossRef Full Textual content | Google Scholar
Richardson, C., Rafiqi, F. H., Karlsson, H. Ok. R., Moleleki, N., Vandewalle, A., Campbell, D. G., et al. (2008). Activation of the Thiazide-Delicate Na+-Cl- Cotransporter by the WNK-Regulated Kinases SPAK and OSR1. J. Cell. Sci. 121, 675–684. doi:10.1242/jcs.025312
PubMed Summary | CrossRef Full Textual content | Google Scholar
Roy, A., Al-Qusairi, L., Donnelly, B. F., Ronzaud, C., Marciszyn, A. L., Gong, F., et al. (2015). Alternatively Spliced Proline-Wealthy Cassettes Hyperlink WNK1 to Aldosterone Motion. J. Clin. Make investments. 125, 3433–3448. doi:10.1172/jci75245
PubMed Summary | CrossRef Full Textual content | Google Scholar
Rudini, N., Felici, A., Giampietro, C., Lampugnani, M., Corada, M., Swirsding, Ok., et al. (2008). VE-cadherin Is a Crucial Endothelial Regulator of TGF-β Signalling. EMBO J. 27, 993–1004. doi:10.1038/emboj.2008.46
PubMed Summary | CrossRef Full Textual content | Google Scholar
Sato, A., Shimizu, M., Goto, T., Masuno, H., Kagechika, H., Tanaka, N., et al. (2020). WNK Regulates Wnt Signalling and β-Catenin Ranges by Interfering with the Interplay between β-Catenin and GID. Commun. Biol. 3, 666. doi:10.1038/s42003-020-01386-2
PubMed Summary | CrossRef Full Textual content | Google Scholar
Schumacher, F.-R., Sorrell, F. J., Alessi, D. R., Bullock, A. N., and Kurz, T. (2014). Structural and Biochemical Characterization of the KLHL3-WNK Kinase Interplay Necessary in Blood Stress Regulation. Biochem. J. 460, 237–246. doi:10.1042/bj20140153
PubMed Summary | CrossRef Full Textual content | Google Scholar
Shahi Thakuri, P., Gupta, M., Singh, S., Joshi, R., Glasgow, E., Lekan, A., et al. (2020). Phytochemicals Inhibit Migration of Triple Unfavorable Breast Most cancers Cells by Focusing on Kinase Signaling. BMC Most cancers 20, 4. doi:10.1186/s12885-019-6479-2
PubMed Summary | CrossRef Full Textual content | Google Scholar
Shekarabi, M., Zhang, J., Khanna, A. R., Ellison, D. H., Delpire, E., and Kahle, Ok. T. (2017). WNK Kinase Signaling in Ion Homeostasis and Human Illness. Cell. Metab. 25, 285–299. doi:10.1016/j.cmet.2017.01.007
PubMed Summary | CrossRef Full Textual content | Google Scholar
Shibata, S., Zhang, J., Puthumana, J., Stone, Ok. L., and Lifton, R. P. (2013). Kelch-like 3 and Cullin 3 Regulate Electrolyte Homeostasis by way of Ubiquitination and Degradation of WNK4. Proc. Natl. Acad. Sci. U.S.A. 110, 7838–7843. doi:10.1073/pnas.1304592110
PubMed Summary | CrossRef Full Textual content | Google Scholar
Shyamasundar, S., Lim, J. P., and Bay, B. H. (2016). miR-93 Inhibits the Invasive Potential of Triple-Unfavorable Breast Most cancers Cells In Vitro by way of Protein Kinase WNK1. Int. J. Oncol. 49, 2629–2636. doi:10.3892/ijo.2016.3761
PubMed Summary | CrossRef Full Textual content | Google Scholar
Sie, Z.-L., Li, R.-Y., Sampurna, B. P., Hsu, P.-J., Liu, S.-C., Wang, H.-D., et al. (2020). WNK1 Kinase Stimulates Angiogenesis to Promote Tumor Development and Metastasis. Cancers 12, 575. doi:10.3390/cancers12030575
PubMed Summary | CrossRef Full Textual content | Google Scholar
Inventory, C., and Schwab, A. (2015). Ion Channels and Transporters in Metastasis. Biochimica Biophysica Acta (BBA) – Biomembr. 1848, 2638–2646. doi:10.1016/j.bbamem.2014.11.012
Solar, H., Lengthy, S., Wu, B., Liu, J., and Li, G. (2020). NKCC1 Involvement within the Epithelial-To-Mesenchymal Transition Is a Prognostic Biomarker in Gliomas. PeerJ 8, e8787. doi:10.7717/peerj.8787
PubMed Summary | CrossRef Full Textual content | Google Scholar
Solar, X., Gao, L., Yu, R. Ok., and Zeng, G. (2006). Down-regulation of WNK1 Protein Kinase in Neural Progenitor Cells Suppresses Cell Proliferation and Migration. J. Neurochem. 99, 1114–1121. doi:10.1111/j.1471-4159.2006.04159.x
PubMed Summary | CrossRef Full Textual content | Google Scholar
Susa, Ok., Sohara, E., Rai, T., Zeniya, M., Mori, Y., Mori, T., et al. (2014). Impaired Degradation of WNK1 and WNK4 Kinases Causes PHAII in Mutant KLHL3 Knock-In Mice. Hum. Mol. Genet. 23, 5052–5060. doi:10.1093/hmg/ddu217
PubMed Summary | CrossRef Full Textual content | Google Scholar
Tan, S.-X., Ng, Y., Burchfield, J. G., Ramm, G., Lambright, D. G., Stöckli, J., et al. (2012). The Rab GTPase-Activating Protein TBC1D4/AS160 Accommodates an Atypical Phosphotyrosine-Binding Area that Interacts with Plasma Membrane Phospholipids to Facilitate GLUT4 Trafficking in Adipocytes. Mol. Cell. Biol. 32, 4946–4959. doi:10.1128/mcb.00761-12
PubMed Summary | CrossRef Full Textual content | Google Scholar
Taylor, C. A., An, S.-W., Kankanamalage, S. G., Stippec, S., Earnest, S., Trivedi, A. T., et al. (2018). OSR1 Regulates a Subset of Inward Rectifier Potassium Channels by way of a Binding Motif Variant. Proc. Natl. Acad. Sci. U.S.A. 115, 3840–3845. doi:10.1073/pnas.1802339115
PubMed Summary | CrossRef Full Textual content | Google Scholar
Tu, S.-w., Bugde, A., Luby-Phelps, Ok., and Cobb, M. H. (2011). WNK1 Is Required for Mitosis and Abscission. Proc. Natl. Acad. Sci. U.S.A. 108, 1385–1390. doi:10.1073/pnas.1018567108
PubMed Summary | CrossRef Full Textual content | Google Scholar
Van Zijl, F., Krupitza, G., and Mikulits, W. (2011). Preliminary Steps of Metastasis: Cell Invasion and Endothelial Transmigration. Mutat. Analysis/Critiques Mutat. Res. 728, 23–34. doi:10.1016/j.mrrev.2011.05.002
Varadi, M., Anyango, S., Deshpande, M., Nair, S., Natassia, C., Yordanova, G., et al. (2021). AlphaFold Protein Construction Database: Massively Increasing the Structural Protection of Protein-Sequence House with Excessive-Accuracy Fashions. Nucleic Acids Res. 50, D439–D444. doi:10.1093/nar/gkab1061
Vidal-Petiot, E., Cheval, L., Faugeroux, J., Malard, T., Doucet, A., Jeunemaitre, X., et al. (2012). A New Methodology for Quantification of Alternatively Spliced Exons Reveals a Extremely Tissue-specific Expression Sample of WNK1 Isoforms. PLoS One 7, e37751. doi:10.1371/journal.pone.0037751
PubMed Summary | CrossRef Full Textual content | Google Scholar
Vitari, A. C., Deak, M., Morrice, N. A., and Alessi, D. R. (2005). The WNK1 and WNK4 Protein Kinases that Are Mutated in Gordon’s Hypertension Syndrome Phosphorylate and Activate SPAK and OSR1 Protein Kinases. Biochem. J. 391, 17–24. doi:10.1042/bj20051180
PubMed Summary | CrossRef Full Textual content | Google Scholar
Vitari, A. C., Thastrup, J., Rafiqi, F. H., Deak, M., Morrice, N. A., Karlsson, H. Ok. R., et al. (2006). Purposeful Interactions of the SPAK/OSR1 Kinases with Their Upstream Activator WNK1 and Downstream Substrate NKCC1. Biochem. J. 397, 223–231. doi:10.1042/bj20060220
PubMed Summary | CrossRef Full Textual content | Google Scholar
Wang, H.-R., Liu, Z., and Huang, C.-L. (2008). Domains of WNK1 Kinase within the Regulation of ROMK1. Am. J. Physiology-Renal Physiology 295, F438–F445. doi:10.1152/ajprenal.90287.2008
PubMed Summary | CrossRef Full Textual content | Google Scholar
Wang, L., Fan, J., Francis, J. M., Georghiou, G., Hergert, S., Li, S., et al. (2017). Built-in Single-Cell Genetic and Transcriptional Evaluation Suggests Novel Drivers of Persistent Lymphocytic Leukemia. Genome Res. 27, 1300–1311. doi:10.1101/gr.217331.116
PubMed Summary | CrossRef Full Textual content | Google Scholar
Wang, J.-f., Zhao, Ok., Chen, Y.-y., Qiu, Y., Zhu, J.-h., Li, B.-p., et al. (2021). NKCC1 Promotes Proliferation, Invasion and Migration in Human Gastric Most cancers Cells by way of Activation of the MAPK-JNK/EMT Signaling Pathway. J. Most cancers 12, 253–263. doi:10.7150/jca.49709
PubMed Summary | CrossRef Full Textual content | Google Scholar
Welch-Reardon, Ok. M., Ehsan, S. M., Wang, Ok., Wu, N., Newman, A. C., Romero-Lopez, M., et al. (2014). Angiogenic Sprouting Is Regulated by Endothelial Cell Expression of Slug. J. Cell. Sci. 127, 2017–2028. doi:10.1242/jcs.143420
PubMed Summary | CrossRef Full Textual content | Google Scholar
Welch-Reardon, Ok. M., Wu, N., and Hughes, C. C. W. (2015). A Function for Partial Endothelial-Mesenchymal Transitions in Angiogenesis? Arterioscler. Thromb. Vasc. Biol. 35, 303–308. doi:10.1161/atvbaha.114.303220
PubMed Summary | CrossRef Full Textual content | Google Scholar
Wilson, F. H., Disse-Nicodème, S., Choate, Ok. A., Ishikawa, Ok., Nelson-Williams, C., Desitter, I., et al. (2001). Human Hypertension Brought on by Mutations in WNK Kinases. Science 293, 1107–1112. doi:10.1126/science.1062844
PubMed Summary | CrossRef Full Textual content | Google Scholar
Xie, J., Wu, T., Xu, Ok., Huang, I. Ok., Cleaver, O., and Huang, C.-L. (2009). Endothelial-Particular Expression of WNK1 Kinase Is Important for Angiogenesis and Coronary heart Growth in Mice. Am. J. Pathology 175, 1315–1327. doi:10.2353/ajpath.2009.090094
PubMed Summary | CrossRef Full Textual content | Google Scholar
Xie, J., Yoon, J., Yang, S.-S., Lin, S.-H., and Huang, C.-L. (2013). WNK1 Protein Kinase Regulates Embryonic Cardiovascular Growth by way of the OSR1 Signaling Cascade. J. Biol. Chem. 288, 8566–8574. doi:10.1074/jbc.m113.451575
PubMed Summary | CrossRef Full Textual content | Google Scholar
Xu, B.-e., English, J. M., Wilsbacher, J. L., Stippec, S., Goldsmith, E. J., and Cobb, M. H. (2000). WNK1, a Novel Mammalian Serine/threonine Protein Kinase Missing the Catalytic Lysine in Subdomain II. J. Biol. Chem. 275, 16795–16801. doi:10.1074/jbc.275.22.16795
PubMed Summary | CrossRef Full Textual content | Google Scholar
Xu, B.-e., Min, X., Stippec, S., Lee, B.-H., Goldsmith, E. J., and Cobb, M. H. (2002). Regulation of WNK1 by an Autoinhibitory Area and Autophosphorylation. J. Biol. Chem. 277, 48456–48462. doi:10.1074/jbc.m207917200
PubMed Summary | CrossRef Full Textual content | Google Scholar
Xu, B.-e., Lee, B.-H., Min, X., Lenertz, L., Heise, C. J., Stippec, S., et al. (2005a). WNK1: Evaluation of Protein Kinase Construction, Downstream Targets, and Potential Roles in Hypertension. Cell. Res. 15, 6–10. doi:10.1038/sj.cr.7290256
Xu, B.-e., Stippec, S., Chu, P.-Y., Lazrak, A., Li, X.-J., Lee, B.-H., et al. (2005b). WNK1 Prompts SGK1 to Regulate the Epithelial Sodium Channel. Proc. Natl. Acad. Sci. U.S.A. 102, 10315–10320. doi:10.1073/pnas.0504422102
PubMed Summary | CrossRef Full Textual content | Google Scholar
Xu, B.-e., Stippec, S., Lazrak, A., Huang, C.-L., and Cobb, M. H. (2005c). WNK1 Prompts SGK1 by a Phosphatidylinositol 3-kinase-dependent and Non-catalytic Mechanism. J. Biol. Chem. 280, 34218–34223. doi:10.1074/jbc.m505735200
PubMed Summary | CrossRef Full Textual content | Google Scholar
Yamada, Ok., Park, H.-M., Rigel, D. F., Dipetrillo, Ok., Whalen, E. J., Anisowicz, A., et al. (2016). Small-molecule WNK Inhibition Regulates Cardiovascular and Renal Perform. Nat. Chem. Biol. 12, 896–898. doi:10.1038/nchembio.2168
PubMed Summary | CrossRef Full Textual content | Google Scholar
Yan, Y., Dalmasso, G., Nguyen, H. T. T., Obertone, T. S., Charrier-Hisamuddin, L., Sitaraman, S. V., et al. (2008). Nuclear Issue-Κb Is a Crucial Mediator of Ste20-like Proline-/Alanine-Wealthy Kinase Regulation in Intestinal Irritation. Am. J. Pathology 173, 1013–1028. doi:10.2353/ajpath.2008.080339
Zagórska, A., Pozo-Guisado, E., Boudeau, J., Vitari, A. C., Rafiqi, F. H., Thastrup, J., et al. (2007). Regulation of Exercise and Localization of the WNK1 Protein Kinase by Hyperosmotic Stress. J. Cell. Biol. 176, 89–100. doi:10.1083/jcb.200605093
PubMed Summary | CrossRef Full Textual content | Google Scholar
Zhang, J., Deng, X., and Kahle, Ok. T. (2016). Leveraging Distinctive Structural Traits of WNK Kinases to Obtain Therapeutic Inhibition. Sci. Sign 9, e3. doi:10.1126/scisignal.aaj2227
PubMed Summary | CrossRef Full Textual content | Google Scholar
Zhou, Y., Solar, W., Chen, N., Xu, C., Wang, X., Dong, Ok., et al. (2017). Discovery of NKCC1 as a Potential Therapeutic Goal to Inhibit Hepatocellular Carcinoma Cell Development and Metastasis. Oncotarget 8, 66328–66342. doi:10.18632/oncotarget.20240
PubMed Summary | CrossRef Full Textual content | Google Scholar

